BioNexus Gene Lab Corp. (BGLC) Stock buybacks
BioNexus Gene Lab Corp. (BGLC) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to BGLCSource: SEC XBRL filings · For reference only · Not investment advice
More BGLC financial trends
BGLC RevenueBGLC Net incomeBGLC Net marginBGLC Gross profitBGLC Gross marginBGLC Operating incomeBGLC Operating marginBGLC Operating cash flowBGLC Free cash flowBGLC Capital expendituresBGLC Return on equityBGLC Dividends paidBGLC Total assetsBGLC Total liabilitiesBGLC Shareholders’ equityBGLC overview →